Ob/Gyn Information Center
Approval from the Food and Drug Administration (FDA) was supported by the Phase 3 Replenish trial which evaluated the safety and efficacy of Bijuva in generally healthy, postmenopausal women with a uterus for the treatment of moderate to severe hot flashes.
Orthopedics Information Center
Multiple pharmacologic therapies have been shown to reduce fracture rates in postmenopausal women with acceptable safety profiles
The Institute of Medicine finds consistent evidence for links with combo HRT, postmenopausal weight gain, radiation and alcohol consumption.
Undergoing mammography for breast cancer once every two years rather than annually does not increase the risk of advanced-stage or large-size tumors.
Investigators posit that endogenous estrogen may have a protective effect against schizophrenia.
Practice Management Information Center
The largest barrier to care for transgender persons is a lack of knowledgeable providers who offer appropriate and culturally competent care.
LGBT practice management includes routine cancer screening in accordance with current guidelines.
A 68-year-old white man presents with 4 weeks of progressively worsening thickening of the skin and plaques on the bilateral nipple and areola. He has no personal or family history of warts or epidermal nevi and has not had hormonal therapy. On examination, he has hyperpigmented, verrucous plaques bilaterally, with no associated erythema or lymphadenopathy.…
Breast cancer is one of the most frequently diagnosed types of cancer in the United States. In 2013, an estimated 232,000 American women will be diagnosed with the disease. Ductal carcinoma and lobular carcinoma are the most common types, occurring in 7 in 10 and 1 in 10 women with breast cancer, respectively.2 Treatment for…
Can thyroid hormone replacement therapy affect bone density?